Market Value302,919,910
Total Holdings57
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GERN / Geron Corporation
/ Fusion Networks Holdings, Inc.
INCY / Incyte Corporation
RNA / Avidity Biosciences, Inc.
IRON / Disc Medicine, Inc.
PFE / Pfizer Inc.
AADI / Aadi Bioscience, Inc.
APLS / Apellis Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
JNJ / Johnson & Johnson
SRPT / Sarepta Therapeutics, Inc. Call
SRPT / Sarepta Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
ETNB / 89bio, Inc. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ROIV / Roivant Sciences Ltd.
PHAT / Phathom Pharmaceuticals, Inc.
KRTX / Karuna Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
ISEE / IVERIC bio Inc
IMGN / ImmunoGen, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
PTGX / Protagonist Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
QURE / uniQure N.V.
RVNC / Revance Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
RXDX / Prometheus Biosciences Inc
FGEN / FibroGen, Inc.
AMAM / Ambrx Biopharma Inc.
KZR / Kezar Life Sciences, Inc.
XFOR / X4 Pharmaceuticals, Inc.
ETNB / 89bio, Inc.
ALT / Altimmune, Inc. Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
ATXS / Astria Therapeutics, Inc.
INBX / Inhibrx Biosciences, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
MRSN / Mersana Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
CTIC / CTI BioPharma Corp
IOVA / Iovance Biotherapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
XENE / Xenon Pharmaceuticals Inc.
BMEA / Biomea Fusion, Inc.
RCUS / Arcus Biosciences, Inc.
VIR / Vir Biotechnology, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
VNDA / Vanda Pharmaceuticals Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
PMVP / PMV Pharmaceuticals, Inc.
MLTX / MoonLake Immunotherapeutics
BTAI / BioXcel Therapeutics, Inc. Call
SWTX / SpringWorks Therapeutics, Inc.
RETA / Reata Pharmaceuticals Inc - Class A Call
MORF / Morphic Holding, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
PCVX / Vaxcyte, Inc.
REPL / Replimune Group, Inc.
FOLD / Amicus Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ALPN / Alpine Immune Sciences, Inc.
VRDN / Viridian Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.